KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Return on Equity (2018 - 2025)

Aquestive Therapeutics has reported Return on Equity over the past 8 years, most recently at 4.44% for Q4 2025.

  • Quarterly results put Return on Equity at 4.44% for Q4 2025, up 360.0% from a year ago — trailing twelve months through Dec 2025 was 4.44% (up 360.0% YoY), and the annual figure for FY2025 was 1.79%, up 126.0%.
  • Return on Equity for Q4 2025 was 4.44% at Aquestive Therapeutics, up from 1.8% in the prior quarter.
  • Over the last five years, Return on Equity for AQST hit a ceiling of 4.44% in Q4 2025 and a floor of 0.08% in Q4 2023.
  • Median Return on Equity over the past 5 years was 0.81% (2022), compared with a mean of 0.94%.
  • Biggest five-year swings in Return on Equity: plummeted -397bps in 2021 and later skyrocketed 360bps in 2025.
  • Aquestive Therapeutics' Return on Equity stood at 0.99% in 2021, then crashed by -51bps to 0.48% in 2022, then crashed by -84bps to 0.08% in 2023, then surged by 1012bps to 0.84% in 2024, then soared by 431bps to 4.44% in 2025.
  • The last three reported values for Return on Equity were 4.44% (Q4 2025), 1.8% (Q3 2025), and 0.97% (Q2 2025) per Business Quant data.